Clinical Characteristics of the Respiratory Subtype in Panic Disorder Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Panic disorder has been suggested to be divided into the respiratory and non-respiratory subtypes in terms of its clinical presentations. The present study aimed to investigate whether there are any differences in treatment response and clinical characteristics between the respiratory and non-respiratory subtypes of panic disorder patients. Methods Among the 48 patients those who completed the study, 25 panic disorder patients were classified as the respiratory subtype, whereas 23 panic disorder patients were classified as the non-respiratory subtype. All patients were treated with escitalopram or paroxetine for 12 weeks. We measured clinical and psychological characteristics before and after pharmacotherapy using the Panic Disorder Severity Scale (PDSS), Albany Panic and Phobic Questionnaire (APPQ), Anxiety Sensitivity Index-Revised (ASI-R), State-Trait Anxiety Inventory (STAI-T, STAI-S), Hamilton Anxiety Rating Scale (HAM-A), and Hamilton Depression Rating Scale (HAM-D). Results The prevalence of the agoraphobia was significantly higher in the respiratory group than the non-respiratory group although there were no differences in gender and medication between the two groups. The respiratory group showed higher scores on the fear of respiratory symptoms of the ASI-R. In addition, after pharmacotherapy, the respiratory group showed more improvement in panic symptoms than the non-respiratory group. Conclusion Panic disorder patients with the respiratory subtype showed more severe clinical presentations, but a greater treatment response to SSRIs than those with non-respiratory subtype. Thus, classification of panic disorder patients as respiratory and non-respiratory subtypes may be useful to predict clinical course and treatment response to SSRIs.
Abstract
Objective Panic disorder has been suggested to be divided into the respiratory and non-respiratory subtypes in terms of its clinical presentations. The present study aimed to investigate whether there are any differences in treatment response and clinical characteristics between the respiratory and non-respiratory subtypes of panic disorder patients. Methods Among the 48 patients those who completed the study, 25 panic disorder patients were classified as the respiratory subtype, whereas 23 panic disorder patients were classified as the non-respiratory subtype. All patients were treated with escitalopram or paroxetine for 12 weeks. We measured clinical and psychological characteristics before and after pharmacotherapy using the Panic Disorder Severity Scale (PDSS), Albany Panic and Phobic Questionnaire (APPQ), Anxiety Sensitivity Index-Revised (ASI-R), State-Trait Anxiety Inventory (STAI-T, STAI-S), Hamilton Anxiety Rating Scale (HAM-A), and Hamilton Depression Rating Scale (HAM-D). Results The prevalence of the agoraphobia was significantly higher in the respiratory group than the non-respiratory group although there were no differences in gender and medication between the two groups. The respiratory group showed higher scores on the fear of respiratory symptoms of the ASI-R. In addition, after pharmacotherapy, the respiratory group showed more improvement in panic symptoms than the non-respiratory group. Conclusion Panic disorder patients with the respiratory subtype showed more severe clinical presentations, but a greater treatment response to SSRIs than those with non-respiratory subtype. Thus, classification of panic disorder patients as respiratory and non-respiratory subtypes may be useful to predict clinical course and treatment response to SSRIs.
참고문헌 (39)
- Kircanski K, "Subtypes of panic attacks: a critical review of the empirical literature", Depress Anxiety, 26, pp.878~887 (2009)
- Onur E, "Panic disorder subtypes: further clinical differences", Depress Anxiety, 24, pp.479~486 (2007)
- Valcnca AM, "Therapeutic response to benzodiazepine in panic disorder subtypes", Sao Paulo Med J, 121, pp.77~80 (2003)
- Klein DF, "False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis", Arch Gen Psychiatry, 50, pp.306~317 (1993)
- Briggs AC, "Subtyping of panic disorder by symptom profile", Br J Psychiatry, 163, pp.201~209 (1993)
- Freire RC, "Panic disorder respiratory subtype: a comparison between responses to hyperventilation and CO2 challenge tests", Psychiatry Res, 157, pp.307~310 (2008)
- Roberson-Nay R, "Panic disorder and its subtypes: a comprehensive analysis of panic symptom heterogeneity using epidemiological and treatment seeking samples", Psychol Med, 41, pp.2411~2421 (2011)
- Sarp A, "Possible subtypes of panic disorder", Turk Psikiyatri Derg, 21, pp.269~279 (2010)
- 하주원, "공황장애 호흡기 아형과 비호흡기 아형의 임상 특성 비교", 생물정신의학, 16(1), pp.46~52 (2009), 대한생물정신의학회
- Freire RC, "Clinical features of respiratory and nocturnal panic disorder subtypes", Psychiatry Res, 152, pp.287~291 (2007)
- Nardi AE, "Panic disorder and control of breathing", Respir Physiol Neurobiol, 167, pp.133~143 (2009)
- Biber B, "Panic disorder subtypes: differential responses to CO2 challenge", Am J Psychiatry, 156, pp.739~744 (1999)
- Nardi AE, "A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam", Psychiatry Res, 137, pp.61~70 (2005)
- de-Melo-Neto VL, "Respiratory and non-respiratory panic disorder subtypes: clinical and quality of life comparisons", Rev Port Pneumol, 15, pp.859~874 (2009)
- Katzelnick DJ, "Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone", Psychiatry (Edgmont), 3, pp.39~49 (2006)
- Freire RC, "New treatment options for panic disorder: clinical trials from 2000 to 2010", Expert Opin Pharmacother, 12, pp.1419~1428 (2011)
- Shear MK, "Multicenter collaborative panic disorder severity scale", Am J Psychiatry, 154, pp.1571~1575 (1997)
- JB K, "Development of the Korean version of the panic disorder severity scale", Korean J Psychopathol, 10, pp.140~151 (2001)
- Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
- Hamilton M, "The assessment of anxiety states by rating", Br J Med Psychol, 32, pp.50~55 (1959)
- Taylor S, "An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample", J Anxiety Disord, 12, pp.463~483 (1998)
- 김지혜, "한국어 확장판 불안 민감도 지수의 타당화 연구", 신경정신의학, 43(1), pp.54~61 (2004), 대한신경정신의학회
- Rapee RM, "Assessment instrument for panic disorder that includes fear of sensation-producing activities: the Albany Panic and Phobia Questionnaire", Anxiety, 1, pp.114~122 (1994)
- 김지혜, "한국판 알마니 공황-공포 질문지 타당화 연구", 신경정신의학, 43(3), pp.329~336 (2004), 대한신경정신의학회
- Bollini P, "Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials", Br J Psychiatry, 174, pp.297~303 (1999)
- Nutt DJ, "Overview of diagnosis and drug treatments of anxiety disorders", CNS Spectr, 10, pp.49~56 (2005)
- Bandelow B, "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care", Int J Psychiatry Clin Pract, 16, pp.77~84 (2012)
- Furukawa TA, "Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale", Depress Anxiety, 26, pp.922~929 (2009)
- Park HJ, "Psychological characteristics of early remitters in patients with panic disorder", PSYCHIATRY RESEARCH, 197(3), pp.237~241 (2012), ELSEVIER IRELAND LTD
- Cox BJ, "Anxiety sensitivity and panic attack symptomatology", Behav Res Ther, 33, pp.833~836 (1995)
- Simon NM, "Changes in anxiety sensitivity with pharmacotherapy for panic disorder", J Psychiatr Res, 38, pp.491~495 (2004)
- Andrisano C, "Newer antidepressants and panic disorder: a meta-analysis", Int Clin Psychopharmacol, 28, pp.33~45 (2013)
- Yeragani VK, "Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report", Neuropsychobiology, 49, pp.53~57 (2004)
- Olsson M, "Paroxetine influences respiration in rats: implications for the treatment of panic disorder", Eur Neuropsychopharmacol, 14, pp.29~37 (2004)
- Bakker A, "SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis", Acta Psychiatr Scand, 106, pp.163~167 (2002)
- Lecrubier Y, "A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators", Acta Psychiatr Scand, 95, pp.145~152 (1997)
- Nardi AE, "A randomized, naturalistic, parallel-group study for the longterm treatment of panic disorder with clonazepam or paroxetine", J Clin Psychopharmacol, 32, pp.120~126 (2012)
- Miyazaki M, "Relationships between anxiety severity, diagnosis of multiple anxiety disorders, and comorbid major depressive disorder", Asian J Psychiatr, 4, pp.293~296 (2011)
- Batelaan NM, "The course of panic attacks in individuals with panic disorder and subthreshold panic disorder: a population-based study", J Affect Disord, 121, pp.30~38 (2010)